4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-19-004276
Chief Business Officer acquired 1,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolan Lisa Chief Business Officer | 2019-02-28 | Option exercise | +1,625 | 23,250 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolan Lisa Chief Business Officer | 2019-02-28 | Option exercise · Restricted Stock Units | −1,625 | 3,250 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…